罕见病知识库 RareSeen

赖氨酸尿性蛋白耐受不良

Lysinuric protein intolerance

定义 英文原文(暂无中文)

A rare disorder of amino acid absorption and transport characterized by a secondary urea cycle disorder with failure to thrive, hepatosplenomegaly, and a wide range of clinical manifestations including hematological (macrophagic activation syndrome or hemophagocytic lymphohistiocytosis, HLH), immune, digestive, renal, pulmonary and/or bones involvement.

别名

高双碱基氨基酸尿症

基本事实

遗传方式
常染色体隐性
发病年龄
婴儿期、新生儿期
患病率
1-9 / 100 000(Europe)

相关基因 1

基因名称关联类型
SLC7A7solute carrier family 7 member 7Disease-causing germline mutation(s) in

临床表型 77

极常见 99–80%1

  • 发育迟滞 HP:0001508

常见 79–30%48

  • 异常出血 HP:0001892
  • 肺间质形态异常 HP:0006530
  • 肾小管形态异常 HP:0000091
  • 丝氨酸代谢异常 HP:0012278
  • 贫血 HP:0001903
  • 精氨酸尿 HP:0003268
  • 骨髓细胞过多 HP:0031020
  • 慢性肾病 HP:0012622
  • 肝硬化 HP:0001394
  • 认知功能损害 HP:0100543
  • 低α-脂蛋白血症 HP:0003233
  • 肾小球滤过率下降 HP:0012213
  • 骨成熟延迟 HP:0002750
  • 腹泻 HP:0002014
  • 循环肝转氨酶水平升高 HP:0002910
  • 血浆瓜氨酸升高 HP:0011966
  • 喂养困难 HP:0011968
  • 婴儿型肌张力减退 HP:0008947
  • 肾小球肾炎 HP:0000099
  • 生长延迟 HP:0001510
  • 血尿 HP:0000790
  • 噬血细胞作用 HP:0012156
  • 肝功能衰竭 HP:0001399
  • 肝脏肿大 HP:0002240
  • 肝脾肿大 HP:0001433
  • 高丙氨酸血症 HP:0003348
  • 高氨血症 HP:0001987
  • 高胆固醇血症 HP:0003124
  • 高谷氨酰胺血症 HP:0003217
  • 高甘氨酸血症 HP:0002154
  • 高赖氨酸尿症 HP:0003297
  • 高脯氨酸血症 HP:0008358
  • 高甘油三酯血症 HP:0002155
  • 高β-脂蛋白血症 HP:0003141
  • 乳酸脱氢酶活性增高 HP:0025435
  • 智力障碍 HP:0001249
  • 肺泡蛋白沉积症 HP:0006517
  • 白细胞减少症 HP:0001882
  • 肾钙质沉着症 HP:0000121
  • 口服厌恶 HP:0012523
  • 骨质减少 HP:0000938
  • 骨质疏松 HP:0000939
  • 蛋白尿 HP:0000093
  • 肾小管功能障碍 HP:0000124
  • 呼吸功能不全 HP:0002093
  • 脂肪泻 HP:0002570
  • 血小板减少症 HP:0001873
  • 呕吐 HP:0002013

偶见 29–5%21

  • 心脏形态异常 HP:0001627
  • 循环免疫球蛋白水平异常 HP:0010701
  • 体液免疫异常 HP:0005368
  • 抗双链DNA 抗体阳性 HP:0020151
  • 昏迷 HP:0001259
  • 肝淀粉样变性 HP:0012280
  • 高血压 HP:0000822
  • 低纤维蛋白原血症 HP:0011900
  • 血清铁蛋白升高 HP:0003281
  • 血清锌含量增高 HP:0011424
  • 昏睡 HP:0001254
  • 巨核细胞减少症 HP:0005548
  • 膜性肾病 HP:0012578
  • 鸟氨酸尿症 HP:0003532
  • 乳清酸尿症 HP:0003218
  • 胰腺炎 HP:0001733
  • 肺纤维化 HP:0002206
  • 肾淀粉样病变 HP:0001917
  • 肾纤维化 HP:0030760
  • 肾小管性酸中毒 HP:0001947
  • 肾小管间质性肾炎 HP:0001970

罕见 <4–1%7

  • 抗核抗体阳性 HP:0003493
  • 循环补体水平降低 HP:0004431
  • 循环抗体水平降低 HP:0004313
  • 生长激素刺激试验反应降低 HP:0000824
  • 循环抗体水平升高 HP:0010702
  • 病理性骨折 HP:0002756
  • 反复细菌感染 HP:0002718

近两年的全球研究 92L2

2024/10 起在 Europe PMC 检索所得,按发表时间倒序显示最近 20 篇。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。

  • 2026-11开放获取
    Essential Oral Single Nutritional Therapy Products for Inherited Metabolic Diseases: Evidence and Consensus Assessment Using a Modified Delphi Method
    Journal of inherited metabolic disease · DOI · Europe PMC
  • 2026-09综述开放获取
    Interface between inborn errors of immunity and rheumatological disorders in children: A pediatrician's conundrum
    World journal of clinical pediatrics · DOI · Europe PMC
  • 2026-09开放获取
    Urinary creatinine in very low gestational age neonates: importance for interpretation of creatinine-normalized urinary amino acids
    Jornal de pediatria · DOI · Europe PMC
  • 2026-09开放获取
    Spectrum of inherited metabolic disorders diagnosed through newborn screening and symptomatic referrals in Eastern Türkiye
    Molecular genetics and metabolism reports · DOI · Europe PMC
  • 2026-08综述开放获取
    Amino Acid Metabolism in Health and Disease
    MedComm · DOI · Europe PMC
  • 2026-08
    Metabolic alterations associated with immune dysfunction in lysinuric protein intolerance
    Molecular genetics and metabolism · DOI · Europe PMC
  • 2026-08综述开放获取
    Vaccination of children with inborn errors of metabolism: safety, immunogenicity, and practical implications
    European journal of pediatrics · DOI · Europe PMC
  • 2026-08开放获取
    The Spanish Uniform Newborn Screening Panel (SUSP): A National Consensus Framework for Harmonized Newborn Screening
    International journal of neonatal screening · DOI · Europe PMC
  • 2026-08综述病例报告开放获取
    From metabolic disorder to autoimmunity: lupus-like immune dysregulation in children with SLC7A7-associated lysinuric protein intolerance
    BMC pediatrics · DOI · Europe PMC
  • 2026-08
    Interstitial Lung Disease in Children: Rare Genetic Variants Beyond Surfactant Dysfunction
    Pediatric pulmonology · DOI · Europe PMC
  • 2026-07开放获取
    Neonatal Acute Liver Failure due to Citrin Deficiency (NALFCD)
    JIMD reports · DOI · Europe PMC
  • 2026-07开放获取
    Pregnancy in Lysinuric Protein Intolerance Complicated by Immune Dysregulation and Severe Thrombocytopenia
    JIMD reports · DOI · Europe PMC
  • 2026-06开放获取
    Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single-center experience
    Frontiers in pediatrics · DOI · Europe PMC
  • 2026-06综述开放获取
    Importance of Recognizing Renal Tubular Disorders as a Cause of Bone Hypomineralization and Fractures in Adults
    Diagnostics (Basel, Switzerland)
  • 2026-06开放获取
    Extension of the Phase 3 Trial of Somatrogon in Children with Growth Hormone Deficiency: 3 Years of Safety and Efficacy
    Hormone research in paediatrics · 被引 1 · DOI · Europe PMC
  • 2026-05开放获取
    Comparison of Heated Humidified High-flow Nasal Cannula and Noninvasive Ventilation in Children with Acute Hypoxemic Respiratory Failure Using Clinical Respiratory Score: A Prospective Observational Study
    Indian journal of critical care medicine : peer-reviewed, official pub · 被引 1 · DOI · Europe PMC
  • 2026-05开放获取
    Comparative Profiles of Pediatric Mendeliome: A Single-Center 572-Whole-Exome Sequencing Study in Xinjiang
    Human heredity · DOI · Europe PMC
  • 2026-05开放获取
    Contrasting the genetic architecture of cardiac glutathione against other organs: unveiling a unique tissue-specific locus
    Mammalian genome : official journal of the International Mammalian Gen · DOI · Europe PMC
  • 2026-05开放获取
    SLC7A7 Downregulation in Monocytes Drives Immunosuppression and Osteosarcoma Progression
    International journal of genomics · DOI · Europe PMC
  • 2026-04综述开放获取
    Lysosomal checkpoints in renal autoimmunity: from antigen processing to metabolic-immune crosstalk
    Frontiers in immunology · DOI · Europe PMC

境外已获批用于本病的药物 0L2

欧盟与美国均未检索到已获批用于本病的药物。

尚未获批的在研药物(1 项)

这些药已被欧盟或美国的监管机构认定为罕见病用药(英文 orphan drug designation,中文行业里通称「孤儿药资格」——「孤儿」说的是这类药市场太小、没有厂商愿意认领,不是在说病人)。但这只是一种监管身份:意味着监管机构给予研发上的激励,不代表这个药已被证明有效,也不代表将来一定能上市,绝大多数最终不会成药。列在这里是为了看清有哪些方向正在被尝试。

  • Prohippur欧盟2016-08-29
    sodium benzoate
    Treatment of lysinuric protein intolerance
    官方记录

数据来自欧洲药品管理局(EMA)的药品与罕见病用药资格公开导出表,以及美国 FDA 的罕见病用药资格数据库(Orphan Drug Product Designation Database)。两边口径不同:欧盟一侧取的是当前状态仍为「已授权」的药品;美国一侧记录的是「曾获批准」这一事实,FDA 的公开表不追踪药物此后是否退市(例如 Relyvrio 于 2024 年撤市,表中仍记为已获批)。请以官方记录页为准。

外部标识与链接

发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号

本页数据来源

  • 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
  • 中文病名:Orphanet 中文包,冻结于 2020-06-01
  • 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)